X T L Biopharmaceuticals reported $332K in Cost of Sales for its fiscal quarter ending in December of 2024.





Cost Of Sales Change Date
Alaunos Therapeutics USD 0 18K Sep/2024
Bioline Rx USD 84K 12K Sep/2025
Teva Pharmaceutical Industries USD 2.06B 120M Dec/2025
X T L Biopharmaceuticals USD 332K 216K Dec/2024